Actively Recruiting

Phase Not Applicable
Age: 25Years - 48Years
FEMALE
NCT07526311

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

Led by Cairo University · Updated on 2026-04-13

40

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

C

Cairo University

Lead Sponsor

K

Kafrelsheikh University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare two surgical techniques for reducing blood loss during transabdominal myomectomy in women with symptomatic uterine fibroids. The main question it aims to answer is whether bilateral uterine artery ligation reduces intraoperative blood loss more effectively than pericervical mechanical tourniquet application, without increasing operative complications. Researchers will compare bilateral uterine artery ligation with pericervical mechanical tourniquet application during open myomectomy to evaluate blood loss and surgical safety. Participants will undergo elective transabdominal myomectomy and will be randomly assigned to one of the two vascular control techniques before myoma enucleation.

CONDITIONS

Official Title

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

Who Can Participate

Age: 25Years - 48Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female participants aged 25 to 48 years
  • Body mass index less than 35 kg/m2
  • Symptomatic uterine myomas requiring surgical treatment
  • Intramural myomas classified as FIGO types 3 to 6
  • Diagnosis confirmed by transvaginal ultrasound and/or magnetic resonance imaging
  • Maximum diameter of the largest myoma 20 cm or less
  • Scheduled for elective transabdominal myomectomy
  • Able and willing to provide written informed consent
Not Eligible

You will not qualify if you...

  • Submucosal, intracavitary, pedunculated subserosal, cervical, or adnexal myomas
  • FIGO types 0, 1, 2, 7, or 8 myomas
  • History of pelvic inflammatory disease or peritonitis
  • Previous abdominal or pelvic surgery for non-obstetric causes
  • Previous uterine surgery
  • Use of hormonal therapy within the previous 3 months
  • Known bleeding disorder
  • Use of anticoagulant or antiplatelet therapy
  • Preoperative hemoglobin less than 10 g/dL
  • Body mass index 35 kg/m2 or greater
  • Intraoperative conversion from myomectomy to hysterectomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cairo University

Cairo, Al-Manial, Egypt, 11956

Actively Recruiting

Loading map...

Research Team

M

Maged Elmohamady Rashedy, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here